<?xml version="1.0" encoding="UTF-8"?>
<ref id="B131-vaccines-07-00053">
 <label>131.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ali</surname>
    <given-names>S.O.</given-names>
   </name>
   <name>
    <surname>Takas</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Nyborg</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Shoemaker</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Kallewaard</surname>
    <given-names>N.L.</given-names>
   </name>
   <name>
    <surname>Chiong</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Dubovsky</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Mallory</surname>
    <given-names>R.M.</given-names>
   </name>
  </person-group>
  <article-title>Evaluation of MEDI8852, an Anti-Influenza A Monoclonal Antibody, in Treating Acute Uncomplicated Influenza</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2018</year>
  <volume>62</volume>
  <fpage>e00694-18</fpage>
  <pub-id pub-id-type="doi">10.1128/AAC.00694-18</pub-id>
  <pub-id pub-id-type="pmid">30150460</pub-id>
 </element-citation>
</ref>
